🎉 Our website is now live! Step into the world of groundbreaking regenerative cell therapies at https://t.co/nf2EyCS0dW
Visit our website now to stay updated on the latest advancements!
#WebsiteLaunch#RegenerativeTherapies
https://t.co/2SXLdsB1Ib
LEAD is super excited to have 6 members going into participatory bodies @MaastrichtU as of September. @LaPointeLab, @DrDonnaYates, Sharon Anyango, Fiona Passanha & Netty Bekkers-Vos will join the University Council. Mark Kawakami will join the Faculty Council of the Law Faculty!
The elections @MaastrichtU are still going on! There are 5155 votes so far - we can do better! Please remind your colleagues to vote as well! https://t.co/JdX6bqiLem
Check out our great candidates: https://t.co/GS4BPHSt0K
@LaPointeLab@cpawley @DrDonnaYates @SchuhmannTeresa
I just voted for the UM university council. Super awesome that we have the opportunity. Just go to https://t.co/SGNviUVxsV, log in, and pick your candidate. All candidates are great & there are also 2 members from the Maastricht Young Academy up for election: Vanessa & Donna.🎉
Our institute members @FionaRosaleen & @LaPointeLab are running for @MaastrichtU University Council. Please show your support and vote here: https://t.co/FEe6xhe5YL. Let's make a difference together! Vote now
Learn more at https://t.co/Clyp2hBqKO.
Attention Postdoctoral Researchers! Join our team (@MERLN_UM) developing (stem) cell therapies for ophthalmic conditions!
We're seeking a talented researcher to help bring a new cell therapy for corneal endothelial disease to the clinic.
Apply now: https://t.co/ddb7pMnIEK
IDR releases new #kidney transmission #ElectronMicroscopy data ahead of its publication - Structural development of the human fetal kidney: new stages and cellular dynamics in nephrogenesis by @anikaschumacher et al from @LaPointeLab.
https://t.co/TFDNG03elP
Also, check out these articles to learn more about Vanessa and Aart
Vanessa LaPointe: https://t.co/P64kZHimOR
Aart van Apeldoorn: https://t.co/ynm4JBuf61
Next @LaPointeLab & Aart van Apeldoorn are working together to bring a new cell therapy for type 1 diabetes to the market, through their company Lighthouse Biomedical.
With this therapy, type 1 diabetic patients would no longer need to inject insulin.
Would you like to do a PhD in The Netherlands? 🇳🇱👇
A PhD position on Computational modeling of fibrotic scarring is available at @MERLN_UM Institute (@MaastrichtU).
More info: https://t.co/f34hovetH6
📢We seek two postdoctoral researchers to join our team in developing (stem) cell therapies. The application deadline is January 31, 2023. More information about the project can be found on Academic Transfer👇
https://t.co/mscOIKDxF4
We start the second day of the annual @NbteNl meeting with an inspiring presentation of @LaPointeLab at @MERLN_UM on cell therapies for regenerating the corneal endothelium. 🤗🤗🤗
Preprint alert! Short summary in 🧵
You can now read the results of our collaborative project with @FionaRosaleen, building on the work of our previous MSc student Lars Robeerst:
https://t.co/Mo4UaQ4x4X. Big thanks to @LaPointeLab @MvanGriensven @ACarlier_PhD 🤍
@MERLN_UM